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Abstract
The aim of this work was to assess the value of the physical status
of human papillomavirus (HPV) DNA as a disease marker for
cervical cancer development in a set of 248 DNA samples
previously genotyped as HPV 16 or 18, by calculating the E2/E6
ratio through real-time PCR. There was a signiﬁcant difference in
integration status according to disease grade for both genotypes
(p <0.001). Furthermore, especially for HPV 18, determining the
DNA physical status could be a useful biomarker in predicting
cervical cancer risk development, with a lower E2/E6 ratio clinically
associated with the development of a precancerous lesion.
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Almost all cervical cancers are related to human papillomavirus
(HPV) infection, and HPV 16 and 18 genotypes are responsible
for more than 70% of the cases worldwide [1–3]. HPV 18 is
more frequently detected in adenocarcinoma and adenosqu-
amous carcinoma, whereas HPV 16 is more associated to
squamous cell carcinoma [4,5]. In Portugal, HPV 16 is the most
frequently detected genotype by cytological grade (19.7%);
HPV 18 has a low prevalence (4.4%) [6].
Integration of HPV into the host genome is a prerequisite
for the development of malignant lesions, resulting from a
disruption in the HPV genome through partial loss of the E2
gene [7,8]. In addition, recent data suggest that integration
frequency in premalignant and malignant lesions varies with
HPV genotype [5,9]. Physical status of HPV DNA (episomal,
linear or concomitant/mixed forms) has also been considered
as a marker of disease progression [10–12]. Absolute quan-
tiﬁcation of E2 and E6 genes by real-time PCR, followed by
calculation of the E2/E6 ratio has been proposed [13], allowing
identiﬁcation of the different forms of the viral DNA. The aim
of this study was to investigate these associations regarding
HPV 18 in comparison with HPV 16 cases.
The study group comprised 248 frozen DNA aliquots of
cervical samples, from women aged 18–65 years (mean age
33.1  9.3 years; median 31 years), genotyped previously as
HPV 16 (n = 132) or HPV 18 (n = 116) by CLART HPV2
(Genomica, Madrid, Spain). The cervical samples were col-
lected in ThinPrep PreservCyt medium (CyticUK, Crawley,
UK) for cytological analyses. Histological evaluation made on
colposcopically directed biopsies was also available (Table 1).
The histological result was applied as the reference standard in
assessing the predictive value of the physical status in cervical
cancer development using the cytological result as baseline.
The physical status of HPV 16 and 18 DNA was assessed by
real-time PCR ampliﬁcation of E2 and E6 genes, as described
previously [14,15]. Real-time PCR was carried out on an ABI
Prism 7000 Sequence Detection System (Applied Biosystems,
Foster City, CA, USA). For each sample, absolute quantiﬁca-
tion of E2 and E6 genes was performed in duplicate,
simultaneously in the same plate.
Mann–Whitney and Kruskal–Wallis non-parametric meth-
ods were used to discriminate differences in DNA physical
status among the different cytological or histological catego-
ries. Student’s t-test analysis was performed to measure the
difference between the mean E2/E6 ratios for both genotypes
through the clinical diagnosis categories. A p value  0.05
(two-sided) was considered statistically signiﬁcant. All analyses
were performed using the IBM SPSS Statistics version 20.0
(IBM Corporation Inc., Armonk, NY, USA).
Among the HPV 16-positive samples, 40.2% (53/132) were
episomal, 58.3% (77/132) presented concomitant forms, and
1.5% (2/132) were in the linear form. The episomal forms were
more frequent in normal cytologies, whereas the concomitant
forms increased according to disease grade (p 0.011; Fig. 1a).
An increasing proportion of concomitant forms was identiﬁed
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from normal histology through to cervical intraepithelial
neoplasia (CIN) grade 3 lesions, ranging from 33.3% (10/30)
to 88.9% (8/9), respectively (p <0.001; Fig. 1b). Concerning
the E2/E6 ratio, no signiﬁcant difference was found between
normal histologies and CIN2 cases (0.959  0.112) (p <0.001;
Fig. 2a).
Among the HPV 18-positive cases, 13.8% (16/116) were
episomal, 65.5% (76/116) presented concomitant forms, and
20.7% (24/116) were in the linear state. Cytologically, the
episomal forms were detected in 15% of the cases, whereas
the concomitant form was the most frequent in every lesion
group (>60.0%). An increasing proportion of linear forms was
related to the severity of the lesion grade (p 0.029; Fig. 1c).
The proportion of concomitant forms decreased from 72.5%
(37/51) to 28.6% (2/7) in CIN1 and CIN3 lesions, respectively,
whereas the proportion of linear forms increased from 24.1%
(13/54) in CIN2 lesions, to 71.4% (5/7) in CIN3 lesions, and
100% (4/4) in adenocarcinomas (ICC) (p <0.001; Fig. 1d).
Considering the E2/E6 ratio, there was a signiﬁcant linear
decrease in the value of the ratio associated with the severity
of lesion grade (0.054  0.112; p <0.001) (Fig. 2b).
The percentage of concomitant and linear forms (72.2%;
179/248) is consistent with other studies [8,13,14]. As
expected, especially for HPV 16, our data showed that
integration may be an early event during carcinogenesis, as
concomitant forms were the most frequently detected
[8,12,13,16–18]. Yet, the fact that even in CIN2 cases
episomal forms were detected could indicate that apart from
HPV 16 integration, other mechanisms might lead to
carcinogenesis. Considering the mean E2/E6 ratio in the
histological diagnosis, values were similar from normal
histology to CIN2 lesions, and only in CIN3 lesions the
mean E2/E6 ratio was considerably lower.
Previous studies determined that the frequency rate of
exclusively episomal forms of HPV 18 ranged from 9.8% to
36.7% in ICC [18,19]. However, in our study no episomal form
TABLE 1. Characteristics of the studied samples
Cases (%)
(n = 248)
HPV 16-positive (%)
(n = 132)
HPV 18-positive (%)
(n = 116)
Cytology
NILM 79 (31.8) 42 (31.8) 37 (31.9)
ASC-US 56 (22.5) 26 (19.7) 30 (25.9)
LSIL 66 (26.6) 35 (26.5) 31 (26.7)
HSIL 41 (16.5) 27 (20.5) 14 (12.1)
ICC 6 (2.4) 2 (1.5) 4 (3.4)
Histology
Normal 30 (12.1) 30 (22.7) 0 (0.0)
CIN1 97 (39.1) 47 (35.6) 51 (44.0)
CIN2 99 (39.9) 44 (33.3) 54 (46.6)
CIN3 16 (6.5) 9 (6.8) 7 (6.0)
ICC 6 (2.4) 2 (1.5) 4 (3.4)
NILM, normal cytology; ASC-US, atypical squamous cells of undetermined
signiﬁcance; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade
squamous intraepithelial lesion; ICC, cervical carcinoma, including adenocarci-
noma; CIN, cervical intraepithelial neoplasia grade 1–3.
(a) (b)
(d)(c)
FIG. 1. Physical status of viral DNA from (a) human papillomavirus (HPV) type 16 according to cytology; (b) HPV 16 according to histology; (c) HPV
18 according to cytology; and (d) HPV 18 according to histology. Data are presented with standard error bars. NILM, normal cytology; ASC-US,
atypical squamous cells of undetermined signiﬁcance; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial
lesion; ICC, cervical carcinoma, including adenocarcinoma; CIN, cervical intraepithelial neoplasia grade 1–3.
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was present in adenocarcinomas, suggesting a more aggressive
biological potential of this genotype, as previously stated [5]. In
fact, we observed a relation between HPV 18 E2/E6 ratio and
disease grade, as shown by a shift from the exclusively
episomal form to the exclusively linear form according to the
severity of the lesion.
Regarding the natural history of HPV, it is important to
manage HPV 16-positive or HPV 18-positive women by
improving diagnosis and taking into account type-speciﬁc
characteristics associated with malignant transformation
[5,12]. Considering the systematic analysis proposed by Saunier
et al. [8], in which a cut-off value for E2/E6 ratio lower than
0.520 represents a higher risk for the development of high-
grade lesions, in this study, 16.7% (22/132) of HPV 16-positive
and 55.2% (64/116) of HPV 18-positive women were at risk.
This study has some limitations. First, it is a cross-sectional
study, precluding the determination of the longitudinal clinical
relevance of this biomarker. Also, the low number of high-
grade lesions included in this study shows the need for further
studies to achieve signiﬁcance in women with cervical cancer.
Further evaluation of the determination of HPV 18 physical
status as a predictive biomarker must be addressed. None-
theless, HPV physical status, especially in women infected with
HPV 18, seems to be important in patient management and
cervical cancer prevention, helping to distinguish the clinical
relevance of HPV infection.
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